Tim J Kruser

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. doi request reprint Pseudoprogression after glioma therapy: a comprehensive review
    Tim J Kruser
    Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA
    Expert Rev Neurother 13:389-403. 2013
  2. doi request reprint Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center K4 B100 CSC, 600 Highland Avenue, Madison, WI 53792
    Technol Cancer Res Treat 12:383-9. 2013
  3. pmc Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors
    Tim J Kruser
    Department of Human Oncology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Clin Cancer Res 16:3639-47. 2010
  4. pmc Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab
    Deric L Wheeler
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Cancer Biol Ther 8:696-703. 2009
  5. doi request reprint Mechanisms of resistance to HER family targeting antibodies
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Exp Cell Res 316:1083-100. 2010
  6. pmc The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patients
    Tim J Kruser
    University of Wisconsin Comprehensive Cancer Center, Department of Human Oncology, Madison, Wisconsin, WI 53705, USA
    Expert Opin Investig Drugs 20:305-7. 2011
  7. doi request reprint Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer
    Julian C Hong
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    Int J Radiat Oncol Biol Phys 87:290-6. 2013
  8. pmc Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 72:534-42. 2008
  9. pmc Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA
    Cancer 117:2629-36. 2011
  10. pmc Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    J Arthroplasty 27:1349-53. 2012

Detail Information

Publications12

  1. doi request reprint Pseudoprogression after glioma therapy: a comprehensive review
    Tim J Kruser
    Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA
    Expert Rev Neurother 13:389-403. 2013
    ..Relative to this, the overlapping terms pseudoprogression and radiation necrosis are clarified to produce an appropriate basis for future consideration and research regarding this important biological phenomenon...
  2. doi request reprint Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center K4 B100 CSC, 600 Highland Avenue, Madison, WI 53792
    Technol Cancer Res Treat 12:383-9. 2013
    ....
  3. pmc Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors
    Tim J Kruser
    Department of Human Oncology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Clin Cancer Res 16:3639-47. 2010
    ..In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models...
  4. pmc Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab
    Deric L Wheeler
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Cancer Biol Ther 8:696-703. 2009
    ....
  5. doi request reprint Mechanisms of resistance to HER family targeting antibodies
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Exp Cell Res 316:1083-100. 2010
    ..In this review, we discuss resistance to antibody-based therapies against the EGFR and HER2, similarities between these resistance profiles, and strategies to overcome resistance to HER family targeting monoclonal antibody therapy...
  6. pmc The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patients
    Tim J Kruser
    University of Wisconsin Comprehensive Cancer Center, Department of Human Oncology, Madison, Wisconsin, WI 53705, USA
    Expert Opin Investig Drugs 20:305-7. 2011
    ..Future studies of dasatinib in NSCLC should examine the agent in combination with EGFR inhibitors and/or cytotoxic chemotherapies...
  7. doi request reprint Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer
    Julian C Hong
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    Int J Radiat Oncol Biol Phys 87:290-6. 2013
    ..We assessed whether more limited neck RT used for early-stage (T1-T2 N0) glottic cancer is associated with increased CVD risk, using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database...
  8. pmc Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 72:534-42. 2008
    ..To examine the interaction between panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, and radiation in head-and-neck squamous cell carcinoma and non-small-cell lung cancer cell lines and xenografts...
  9. pmc Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA
    Cancer 117:2629-36. 2011
    ..5 to 8 weeks of treatment. The authors report on the safety and efficacy of an expedited radiotherapy course for salvage prostate radiotherapy...
  10. pmc Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    J Arthroplasty 27:1349-53. 2012
    ..3%). Further study is needed to establish optimal selection criteria for HO prophylaxis after SRA...
  11. ncbi request reprint The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA edu
    Technol Cancer Res Treat 8:149-58. 2009
    ..Hybrid PET/CT imaging at the time of treatment planning may be highly informative and an economical manner in which to obtain PET imaging, with the dual goals of staging and treatment planning...
  12. doi request reprint Multidisciplinary management of colorectal brain metastases: a retrospective study
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Cancer 113:158-65. 2008
    ..The incidence of brain metastases (BM) from colorectal cancer (CRC) is increasing, and the management of this previously rare complication at a single institution is reported...